SCHEMBL24115035

SCHEMBL24115035

C/C(=C\CN(C)C(=O)C(NC(=O)[C@H]1CCCCN1C(C)C)C(C)(C)C)C(=O)N[C@H](CCC(=O)NCCN1C(=O)C=CC1=O)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22309342 0.89 TUBB1 (0.36) —
SCHEMBL20732462 0.89 TUBB1 (0.36) —
SCHEMBL24114977 0.83 CMA1 (0.35) —
SCHEMBL22111216 0.83 XIAP (0.31) —
SCHEMBL22101084 0.83 AKT1 (0.34) —
SCHEMBL22309078 0.82 TUBB1 (0.43) —
SCHEMBL24410271 0.78 TUBB1 (0.33) —
SCHEMBL24574471 0.77 TUBB1 (0.37) —
SCHEMBL22309308 0.77 TUBB1 (0.34) —
SCHEMBL22309232 0.77 AKT1 (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3925668-A1 HEMIASTERLIN DERIVATIVE HAVING CYSTEINE RESIDUE Sumitomo Dainippon Pharma Co., Ltd. (JP) 2021-12-22 — — EP disclosed
Send feedback